TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUM
Authors:
- 1 May 1982
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 16 (5) , 515-524
Abstract
A controlled therapeutic trial on seventy‐four 70‐year‐old women was carried out with the purpose of finding the optimal treatment for post menopausal osteoporosis. The bone mineral content (BMC) was measured by 125I‐photonabsorptiometry at two sites in the distal part of the forearms, where the trabecular/cortical ratio is 0·25 and 1·5, respectively. Radiographs were done on the right hand to measure the metacarpal bone mass (cortical area/total area = CA/TA).After observing the spontaneous course of bone loss for 6 months the participants were allocated at random to 12 months’treatment with 1,25‐dihydroxycholecalciferol [1,25(OH)2D3] and oestrogen/gestagen, alone or in combination, and calcium. The groups treated with oestrogen/gestagen [with or without 1,25(OH)2D3] showed a highly significant increase in BMC. In contrast bone mineral remained unchanged or decreased in both the calcium and the 1,25(OH)2D3 groups with a tendency towards more pronounced negative bone balance in the 1,25‐(OH)2D3 group.Seven out of nineteen patients on 1,25(OH)2D3 developed hypercalcaemia, which necessitated a reduction in dosage. It is concluded that the new vitamin D metabolite, 1,25(OH)2 D3, given in clinically acceptable doses, is without value in the treatment of post menopausal osteoporosis.Keywords
This publication has 21 references indexed in Scilit:
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- Estrogen Use in Postmenopausal Women — Costs, Risks, and BenefitsNew England Journal of Medicine, 1980
- Estrogen replacement therapy1980
- Treatment of spinal osteoporosis in postmenopausal women.BMJ, 1980
- Intestinal Calcium Absorption and Serum Vitamin D Metabolites in Normal Subjects and Osteoporotic PatientsJournal of Clinical Investigation, 1979
- 1,25 (OH)2Vitamin D3in Osteoporosis - A Pilot StudyHormone and Metabolic Research, 1979
- VITAMIN-D ANALOGUES AND RENAL FUNCTIONThe Lancet, 1978
- DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROLThe Lancet, 1978
- TREATMENT OF SENILE OSTEOPOROSIS WITH 1α‐HYDROXYVITAMIN D3Clinical Endocrinology, 1977
- Estimation of Total Body Calcium from the Bone Mineral Content of the ForearmScandinavian Journal of Clinical and Laboratory Investigation, 1975